The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

NCT06041399 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2023-09-18

No results posted yet for this study

Summary

The goal of this observational study is to explore the relationship between related blood indicators and diabetic peripheral neuropathy.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DRUG

hypoglycemic Agents(metformin)

patients treated with hypoglycemic Agents(metformin)

DRUG

lipid-lowering drug(Statin)

patients treated with lipid-lowering drug(Statin)

Sponsors & Collaborators

  • First Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-01
Primary Completion
2022-12-18
Completion
2025-01-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06041399 on ClinicalTrials.gov